Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004219287 | SCV003727950 | uncertain significance | not specified | 2021-08-13 | criteria provided, single submitter | clinical testing | The c.1031T>C (p.L344P) alteration is located in exon 10 (coding exon 10) of the UNC13A gene. This alteration results from a T to C substitution at nucleotide position 1031, causing the leucine (L) at amino acid position 344 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Prevention |
RCV003954029 | SCV004784481 | likely benign | UNC13A-related disorder | 2022-03-29 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |